[{"AccountsAndOtherReceivablesNetCurrent_0_Q2_USD":9025000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":66887000.0,"OperatingLeasePayments_1_Q2_USD":8258000.0,"OperatingLeasePayments_2_Q2_USD":16370000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":87090000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.03,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":2450000.0,"OtherAssetsCurrent_0_Q2_USD":5111000.0,"OtherAssetsNoncurrent_0_Q2_USD":1506000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":27860000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":5442000.0,"PaymentsOfDividendsMinorityInterest_2_Q2_USD":9398000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":20402000.0,"PaymentsToAcquireInterestInSubsidiariesAndAffiliates_2_Q2_USD":0.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":3301000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PreferredStockSharesAuthorized_0_Q2_shares":500000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":9028000.0,"OperatingLeaseLiability_0_Q2_USD":94747000.0,"OperatingLeaseCost_2_Q2_USD":15624000.0,"OperatingLeaseCost_1_Q2_USD":7895000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q2_USD":1510000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_Q2_USD":3182000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-14680000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-33375000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":35556000.0,"NetIncomeLoss_1_Q2_USD":12436000.0,"NetIncomeLoss_2_Q2_USD":20609000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":5036000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":8749000.0,"NoncashOrPartNoncashAcquisitionPayablesAssumed1_2_Q2_USD":1000000.0,"NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1_2_Q2_USD":287000.0,"NonoperatingIncomeExpense_1_Q2_USD":-191000.0,"NonoperatingIncomeExpense_2_Q2_USD":-383000.0,"NumberOfBusinessesAcquired_0_Q2_Clinic":8.0,"NumberOfOperatingSegments_2_Q2_Segment":2.0,"NumberOfReportableSegments_2_Q2_Segment":2.0,"NumberOfStatesInWhichEntityOperates_0_Q2_State":39.0,"OperatingIncomeLoss_1_Q2_USD":22230000.0,"OperatingIncomeLoss_2_Q2_USD":37252000.0,"PreferredStockValue_0_Q2_USD":0.0,"MinorityInterest_0_Q2_USD":963000.0,"ProceedsFromDivestitureOfBusinessesNetOfCashDivested_2_Q2_USD":-168000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":128000000.0,"ShortTermLeaseCost_1_Q2_USD":361000.0,"ShortTermLeaseCost_2_Q2_USD":729000.0,"StockholdersEquity_0_Q2_USD":283848000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":284811000.0,"StockholdersEquityOther_1_Q2_USD":-124000.0,"StockholdersEquityOther_2_Q2_USD":-9000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":0.0,"SharesIssuedPricePerShare_0_Q2_USD":115.87,"StockRepurchasedDuringPeriodShares_2_Q2_shares":0.0,"TreasuryStockShares_0_Q2_shares":2214737.0,"TreasuryStockValue_0_Q2_USD":31628000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_2_Q2_USD":0.0,"VariableLeaseCost_1_Q2_USD":1628000.0,"VariableLeaseCost_2_Q2_USD":3239000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":12902000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":12886000.0,"TaxesPayableCurrent_0_Q2_USD":4547000.0,"ShareBasedCompensation_2_Q2_USD":3405000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":22948000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":12074000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":7000.0,"ProfitLoss_1_Q2_USD":17472000.0,"ProfitLoss_2_Q2_USD":29358000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":93524000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":21560000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":1364000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":2564000.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q2_USD":143337000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":106000000.0,"RepaymentsOfNotesPayable_2_Q2_USD":4207000.0,"RestructuringCharges_1_Q2_USD":-22000.0,"RestructuringCharges_2_Q2_USD":15000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":216286000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":126928000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":239296000.0,"Revenues_1_Q2_USD":126928000.0,"Revenues_2_Q2_USD":239296000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":12976000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":20873000.0,"ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_2_Q2_USD":32000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":12902000.0,"LongTermNotesPayable_0_Q2_USD":821000.0,"LongTermDebtNoncurrent_0_Q2_USD":38821000.0,"CostsAndExpenses_1_Q2_USD":92624000.0,"CostsAndExpenses_2_Q2_USD":179096000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":3160000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":8281000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":5484000.0,"DividendsCommonStockCash_1_Q2_USD":4514000.0,"DividendsCommonStockCash_2_Q2_USD":9028000.0,"EarningsPerShareBasic_1_Q2_USD":0.82,"CommonStockValue_0_Q2_USD":151000.0,"EarningsPerShareBasic_2_Q2_USD":1.03,"EarningsPerShareDiluted_2_Q2_USD":1.03,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.2555,"EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2_Q2_pure":0.2625,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":24378000.0,"FurnitureAndFixturesGross_0_Q2_USD":57538000.0,"GainLossOnSaleOfInterestInProjects_1_Q2_USD":0.0,"GainLossOnSaleOfInterestInProjects_2_Q2_USD":0.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-106000.0,"EarningsPerShareDiluted_1_Q2_USD":0.82,"CommonStockSharesIssued_0_Q2_shares":15121669.0,"CommonStockSharesAuthorized_0_Q2_shares":20000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"AccountsPayableTradeCurrent_0_Q2_USD":1782000.0,"AccountsReceivableNetCurrent_0_Q2_USD":45144000.0,"AccruedInsuranceCurrent_0_Q2_USD":2316000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":44720000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":71964000.0,"AdditionalPaidInCapital_0_Q2_USD":99039000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1754000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":3403000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":2435000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":916000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":1738000.0,"Assets_0_Q2_USD":622958000.0,"AssetsCurrent_0_Q2_USD":79699000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":20419000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":20419000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-12499000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.35,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.7,"Goodwill_0_Q2_USD":373887000.0,"LongTermLineOfCredit_0_Q2_USD":38000000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":27814000.0,"GoodwillImpairmentLoss_2_Q2_USD":0.0,"LeaseholdImprovementsGross_0_Q2_USD":35986000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":100672000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":9374000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":28048000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":9460000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":15724000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":22301000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":15765000.0,"LeaseCost_2_Q2_USD":19592000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":5925000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":622958000.0,"LiabilitiesCurrent_0_Q2_USD":75379000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":844000.0,"LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_1_Q2_pure":0.003,"LongTermDebt_0_Q2_USD":39838000.0,"LongTermDebtCurrent_0_Q2_USD":1017000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":821000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":1017000.0,"Liabilities_0_Q2_USD":194810000.0,"LeaseCost_1_Q2_USD":9884000.0,"LaborAndRelatedExpense_2_Q2_USD":132681000.0,"LaborAndRelatedExpense_1_Q2_USD":68866000.0,"GoodwillPurchaseAccountingAdjustments_2_Q2_USD":427000.0,"GrossProfit_1_Q2_USD":34304000.0,"GrossProfit_2_Q2_USD":60200000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_2_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":22039000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":36869000.0,"IncomeTaxesPaidNet_2_Q2_USD":6967000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":4567000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":7511000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-3672000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":5325000.0,"IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_2_Q2_USD":-129000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":602000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":255000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":59216000.0,"InterestAndOtherIncome_1_Q2_USD":46000.0,"InterestAndOtherIncome_2_Q2_USD":100000.0,"InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_2_Q2_USD":0.0,"InterestPaidNet_2_Q2_USD":741000.0,"GoodwillImpairmentLoss_1_Q2_USD":0.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":12886000.0,"Ticker":"USPH","CIK":"885978","name":"U S PHYSICAL THERAPY INC \/NV","OfficialName":"U.S. Physical Therapy Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1366569153.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20210809"}]